JAK2 and B-cell chronic lymphocytic leukemia: While familial relative risks attributed to this variant are smaller (e.g., <3% for Chronic Lymphatic Leukemia (CLL)), the genotypic relative risks reported for JAK2-positive MPNs are among the highest described in genome-wide association studies [92].